THE INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER
Cancer is the leading cause of death in Canada and is responsible for 30% of all deaths. The Canadian Cancer Society estimated 196,900 new cases of cancer and 78,000 deaths from cancer will occur in Canada in 2015. Within a few decades only, scientific research has led to the development of treatments that have greatly increased the survival rate to certain types of cancers. However, medicine does not yet have solutions to most cancers. Future progress depends on basic research that allows a better understanding of the biological mechanisms that are perturbed in this disease.
THE INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER
Industry:
Biopharma Medical Device
Founded:
2003-01-01
Status:
Active
Contact:
+ 514 343-7770
Total Funding:
10 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Font Awesome Domain Not Resolving
Similar Organizations
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Current Employees Featured
Founder
Investors List
Fonds d'accélération des collaborations en santé (FACS)
Fonds d'accélération des collaborations en santé (FACS) investment in Grant - The Institute for Research in Immunology and Cancer